ID   ADCY3_HUMAN             Reviewed;        1144 AA.
AC   O60266; B3KT86; Q53T54; Q9UDB1;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 3.
DT   07-APR-2021, entry version 200.
DE   RecName: Full=Adenylate cyclase type 3;
DE            EC=4.6.1.1;
DE   AltName: Full=ATP pyrophosphate-lyase 3;
DE   AltName: Full=Adenylate cyclase type III;
DE            Short=AC-III;
DE   AltName: Full=Adenylate cyclase, olfactive type;
DE   AltName: Full=Adenylyl cyclase 3 {ECO:0000305};
DE            Short=AC3 {ECO:0000303|PubMed:9920776};
GN   Name=ADCY3; Synonyms=KIAA0511;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT PRO-107, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9920776; DOI=10.1006/bbrc.1998.9983;
RA   Yang B., He B., Abdel-Halim S.M., Tibell A., Brendel M.D., Bretzel R.G.,
RA   Efendic S., Hillert J.;
RT   "Molecular cloning of a full-length cDNA for human type 3 adenylyl cyclase
RT   and its expression in human islets.";
RL   Biochem. Biophys. Res. Commun. 254:548-551(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 212-1144 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 984-1060 (ISOFORM 1/2).
RX   PubMed=8476432; DOI=10.1006/bbrc.1993.1415;
RA   Hellevuo K., Yoshimura M., Kao M., Hoffman P.L., Cooper D.M.F.,
RA   Tabakoff B.;
RT   "A novel adenylyl cyclase sequence cloned from the human erythroleukemia
RT   cell line.";
RL   Biochem. Biophys. Res. Commun. 192:311-318(1993).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11549699; DOI=10.1210/jcem.86.9.7837;
RA   Cote M., Guillon G., Payet M.D., Gallo-Payet N.;
RT   "Expression and regulation of adenylyl cyclase isoforms in the human
RT   adrenal gland.";
RL   J. Clin. Endocrinol. Metab. 86:4495-4503(2001).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=15705663; DOI=10.1210/me.2004-0318;
RA   Livera G., Xie F., Garcia M.A., Jaiswal B., Chen J., Law E., Storm D.R.,
RA   Conti M.;
RT   "Inactivation of the mouse adenylyl cyclase 3 gene disrupts male fertility
RT   and spermatozoon function.";
RL   Mol. Endocrinol. 19:1277-1290(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-525, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   POLYMORPHISM, INVOLVEMENT IN BMIQ19, AND INVOLVEMENT IN OBESITY.
RX   PubMed=29311636; DOI=10.1038/s41588-017-0022-7;
RA   Grarup N., Moltke I., Andersen M.K., Dalby M., Vitting-Seerup K., Kern T.,
RA   Mahendran Y., Joersboe E., Larsen C.V.L., Dahl-Petersen I.K., Gilly A.,
RA   Suveges D., Dedoussis G., Zeggini E., Pedersen O., Andersson R.,
RA   Bjerregaard P., Joergensen M.E., Albrechtsen A., Hansen T.;
RT   "Loss-of-function variants in ADCY3 increase risk of obesity and type 2
RT   diabetes.";
RL   Nat. Genet. 50:172-174(2018).
RN   [11]
RP   POLYMORPHISM, INVOLVEMENT IN BMIQ19, INVOLVEMENT IN OBESITY, VARIANT
RP   OBESITY PHE-1118 DEL, AND VARIANT ILE-64.
RX   PubMed=29311637; DOI=10.1038/s41588-017-0023-6;
RA   Saeed S., Bonnefond A., Tamanini F., Mirza M.U., Manzoor J., Janjua Q.M.,
RA   Din S.M., Gaitan J., Milochau A., Durand E., Vaillant E., Haseeb A.,
RA   De Graeve F., Rabearivelo I., Sand O., Queniat G., Boutry R., Schott D.A.,
RA   Ayesha H., Ali M., Khan W.I., Butt T.A., Rinne T., Stumpel C.,
RA   Abderrahmani A., Lang J., Arslan M., Froguel P.;
RT   "Loss-of-function mutations in ADCY3 cause monogenic severe obesity.";
RL   Nat. Genet. 50:175-179(2018).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP in
CC       response to G-protein signaling. Participates in signaling cascades
CC       triggered by odorant receptors via its function in cAMP biosynthesis.
CC       Required for the perception of odorants. Required for normal sperm
CC       motility and normal male fertility. Plays a role in regulating insulin
CC       levels and body fat accumulation in response to a high fat diet.
CC       {ECO:0000250|UniProtKB:Q8VHH7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP = 3',5'-cyclic AMP + diphosphate; Xref=Rhea:RHEA:15389,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58165; EC=4.6.1.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P30803};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P30803};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with manganese
CC       (in vitro). {ECO:0000250|UniProtKB:P30803};
CC   -!- ACTIVITY REGULATION: Activated by forskolin. After forskolin treatment,
CC       activity is further increased by calcium/calmodulin. In the absence of
CC       forskolin, calcium/calmodulin has little effect on enzyme activity.
CC       {ECO:0000250|UniProtKB:P21932}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11549699};
CC       Multi-pass membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:11549699}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q8VHH7}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P21932}. Note=Also detected in the cytoplasm,
CC       close to lipid droplets. {ECO:0000269|PubMed:11549699}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60266-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60266-2; Sequence=VSP_055813, VSP_055814, VSP_055815;
CC   -!- TISSUE SPECIFICITY: Detected in zona glomerulosa and zona fasciculata
CC       in the adrenal gland (at protein level) (PubMed:11549699). Expressed in
CC       brain, heart, kidney, liver, lung, pancreas islets, placenta, and
CC       skeletal muscle (PubMed:9920776). Detected in testis (PubMed:15705663).
CC       {ECO:0000269|PubMed:11549699, ECO:0000269|PubMed:15705663,
CC       ECO:0000269|PubMed:9920776}.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane helices
CC       each; both are required for catalytic activity. Isolated N-terminal or
CC       C-terminal modules have no catalytic activity, but when they are
CC       brought together, enzyme activity is restored. The active site is at
CC       the interface of the two modules. {ECO:0000250|UniProtKB:P30803}.
CC   -!- PTM: Sumoylated. Sumoylation is required for targeting ot olfactory
CC       cilia. {ECO:0000250|UniProtKB:P21932}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q8VHH7}.
CC   -!- PTM: Rapidly phosphorylated after stimulation by odorants or forskolin.
CC       Phosphorylation by CaMK2 at Ser-1076 down-regulates enzyme activity.
CC       {ECO:0000250|UniProtKB:Q8VHH7}.
CC   -!- POLYMORPHISM: Genetic variations at the ADCY3 locus define the body
CC       mass index quantitative trait locus 19 (BMIQ19) [MIM:617885]. Variance
CC       in body mass index is a susceptibility factor for obesity.
CC       {ECO:0000269|PubMed:29311636, ECO:0000269|PubMed:29311637}.
CC   -!- DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized by
CC       an increase of body weight beyond the limitation of skeletal and
CC       physical requirements, as the result of excessive accumulation of body
CC       fat. {ECO:0000269|PubMed:29311636, ECO:0000269|PubMed:29311637}.
CC       Note=Disease susceptibility is associated with variants affecting the
CC       gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF033861; AAD13403.1; -; mRNA.
DR   EMBL; AK095173; BAG52998.1; -; mRNA.
DR   EMBL; AC012073; AAY14787.1; -; Genomic_DNA.
DR   EMBL; BC126235; AAI26236.1; -; mRNA.
DR   EMBL; AB011083; BAA25437.1; -; mRNA.
DR   CCDS; CCDS1715.1; -. [O60266-1]
DR   RefSeq; NP_001307542.1; NM_001320613.1.
DR   RefSeq; NP_004027.2; NM_004036.4. [O60266-1]
DR   BioGRID; 106623; 23.
DR   IntAct; O60266; 13.
DR   MINT; O60266; -.
DR   STRING; 9606.ENSP00000260600; -.
DR   BindingDB; O60266; -.
DR   ChEMBL; CHEMBL2097167; -.
DR   GlyGen; O60266; 1 site.
DR   iPTMnet; O60266; -.
DR   PhosphoSitePlus; O60266; -.
DR   BioMuta; ADCY3; -.
DR   EPD; O60266; -.
DR   jPOST; O60266; -.
DR   MassIVE; O60266; -.
DR   MaxQB; O60266; -.
DR   PaxDb; O60266; -.
DR   PeptideAtlas; O60266; -.
DR   PRIDE; O60266; -.
DR   ProteomicsDB; 3671; -.
DR   ProteomicsDB; 49298; -. [O60266-1]
DR   Antibodypedia; 4130; 137 antibodies.
DR   DNASU; 109; -.
DR   Ensembl; ENST00000260600; ENSP00000260600; ENSG00000138031. [O60266-1]
DR   GeneID; 109; -.
DR   KEGG; hsa:109; -.
DR   UCSC; uc002rfs.5; human. [O60266-1]
DR   CTD; 109; -.
DR   DisGeNET; 109; -.
DR   GeneCards; ADCY3; -.
DR   HGNC; HGNC:234; ADCY3.
DR   HPA; ENSG00000138031; Low tissue specificity.
DR   MalaCards; ADCY3; -.
DR   MIM; 600291; gene.
DR   MIM; 601665; phenotype.
DR   MIM; 617885; phenotype.
DR   neXtProt; NX_O60266; -.
DR   OpenTargets; ENSG00000138031; -.
DR   PharmGKB; PA164741137; -.
DR   VEuPathDB; HostDB:ENSG00000138031.14; -.
DR   eggNOG; KOG3619; Eukaryota.
DR   GeneTree; ENSGT00940000156549; -.
DR   HOGENOM; CLU_001072_2_4_1; -.
DR   InParanoid; O60266; -.
DR   OrthoDB; 154265at2759; -.
DR   PhylomeDB; O60266; -.
DR   TreeFam; TF313845; -.
DR   PathwayCommons; O60266; -.
DR   Reactome; R-HSA-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-170660; Adenylate cyclase activating pathway.
DR   Reactome; R-HSA-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   Reactome; R-HSA-9664323; FCGR3A-mediated IL10 synthesis.
DR   SIGNOR; O60266; -.
DR   BioGRID-ORCS; 109; 12 hits in 994 CRISPR screens.
DR   ChiTaRS; ADCY3; human.
DR   GeneWiki; ADCY3; -.
DR   GenomeRNAi; 109; -.
DR   Pharos; O60266; Tbio.
DR   PRO; PR:O60266; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O60266; protein.
DR   Bgee; ENSG00000138031; Expressed in tibial nerve and 234 other tissues.
DR   ExpressionAtlas; O60266; baseline and differential.
DR   Genevisible; O60266; HS.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004016; F:adenylate cyclase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007340; P:acrosome reaction; ISS:UniProtKB.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006171; P:cAMP biosynthetic process; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; ISS:UniProtKB.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0030317; P:flagellated sperm motility; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; TAS:Reactome.
DR   GO; GO:0008355; P:olfactory learning; ISS:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0007608; P:sensory perception of smell; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007338; P:single fertilization; ISS:UniProtKB.
DR   CDD; cd07302; CHD; 2.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calmodulin-binding; cAMP biosynthesis;
KW   Cell membrane; Cell projection; Cytoplasm; Glycoprotein; Golgi apparatus;
KW   Isopeptide bond; Lyase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Obesity; Olfaction; Phosphoprotein; Reference proteome;
KW   Repeat; Sensory transduction; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..1144
FT                   /note="Adenylate cyclase type 3"
FT                   /id="PRO_0000195687"
FT   TOPO_DOM        1..79
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        80..100
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        105..125
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        139..159
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        173..193
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        226..246
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        381..401
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        402..632
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        633..653
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        664..684
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        708..728
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        754..774
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        775..795
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        833..853
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        854..1144
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         324..329
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   NP_BIND         366..368
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   NP_BIND         1062..1064
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   NP_BIND         1069..1073
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   METAL           324
FT                   /note="Magnesium 1; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           324
FT                   /note="Magnesium 2; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           325
FT                   /note="Magnesium 2; via carbonyl oxygen; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           368
FT                   /note="Magnesium 1; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           368
FT                   /note="Magnesium 2; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         412
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         975
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1109
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   MOD_RES         525
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHH7"
FT   MOD_RES         1076
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHH7"
FT   CARBOHYD        736
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        465
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO3)"
FT                   /evidence="ECO:0000250|UniProtKB:P21932"
FT   VAR_SEQ         1..389
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055813"
FT   VAR_SEQ         452
FT                   /note="G -> GGSKIEERLYSCVVAPTLRLRWE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055814"
FT   VAR_SEQ         725..770
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055815"
FT   VARIANT         64
FT                   /note="N -> I (in dbSNP:rs541941351)"
FT                   /evidence="ECO:0000269|PubMed:29311637"
FT                   /id="VAR_080791"
FT   VARIANT         107
FT                   /note="S -> P (in dbSNP:rs11676272)"
FT                   /evidence="ECO:0000269|PubMed:9920776"
FT                   /id="VAR_048248"
FT   VARIANT         1118
FT                   /note="Missing (in OBESITY; risk factor;
FT                   dbSNP:rs750852737)"
FT                   /evidence="ECO:0000269|PubMed:29311637"
FT                   /id="VAR_080792"
SQ   SEQUENCE   1144 AA;  128960 MW;  B75D39DD0A8ACA12 CRC64;
     MPRNQGFSEP EYSAEYSAEY SVSLPSDPDR GVGRTHEISV RNSGSCLCLP RFMRLTFVPE
     SLENLYQTYF KRQRHETLLV LVVFAALFDC YVVVMCAVVF SSDKLASLAV AGIGLVLDII
     LFVLCKKGLL PDRVTRRVLP YVLWLLITAQ IFSYLGLNFA RAHAASDTVG WQVFFVFSFF
     ITLPLSLSPI VIISVVSCVV HTLVLGVTVA QQQQEELKGM QLLREILANV FLYLCAIAVG
     IMSYYMADRK HRKAFLEARQ SLEVKMNLEE QSQQQENLML SILPKHVADE MLKDMKKDES
     QKDQQQFNTM YMYRHENVSI LFADIVGFTQ LSSACSAQEL VKLLNELFAR FDKLAAKYHQ
     LRIKILGDCY YCICGLPDYR EDHAVCSILM GLAMVEAISY VREKTKTGVD MRVGVHTGTV
     LGGVLGQKRW QYDVWSTDVT VANKMEAGGI PGRVHISQST MDCLKGEFDV EPGDGGSRCD
     YLEEKGIETY LIIASKPEVK KTATQNGLNG SALPNGAPAS SKSSSPALIE TKEPNGSAHS
     SGSTSEKPEE QDAQADNPSF PNPRRRLRLQ DLADRVVDAS EDEHELNQLL NEALLERESA
     QVVKKRNTFL LSMRFMDPEM ETRYSVEKEK QSGAAFSCSC VVLLCTALVE ILIDPWLMTN
     YVTFMVGEIL LLILTICSLA AIFPRAFPKK LVAFSTWIDR TRWARNTWAM LAIFILVMAN
     VVDMLSCLQY YTGPSNATAG METEGSCLEN PKYYNYVAVL SLIATIMLVQ VSHMVKLTLM
     LLVAGAVATI NLYAWRPVFD EYDHKRFREH DLPMVALEQM QGFNPGLNGT DRLPLVPSKY
     SMTVMVFLMM LSFYYFSRHV EKLARTLFLW KIEVHDQKER VYEMRRWNEA LVTNMLPEHV
     ARHFLGSKKR DEELYSQTYD EIGVMFASLP NFADFYTEES INNGGIECLR FLNEIISDFD
     SLLDNPKFRV ITKIKTIGST YMAASGVTPD VNTNGFASSN KEDKSERERW QHLADLADFA
     LAMKDTLTNI NNQSFNNFML RIGMNKGGVL AGVIGARKPH YDIWGNTVNV ASRMESTGVM
     GNIQVVEETQ VILREYGFRF VRRGPIFVKG KGELLTFFLK GRDKLATFPN GPSVTLPHQV
     VDNS
//
